Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2

References

• Benson JR, Jatoi I. The global breast cancer burden. Future Oncol 2012; 8:697-702; PMID:22764767; http://dx.doi.org/10.2217/fon.12.61
   PubMed Web of Science ®Google Scholar
• Deng Z, Yan F, Jin Q, Li F, Wu J, Liu X, Zheng H. Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound. J Control Release 2014; 174:109-16; PMID:24287101; http://dx.doi.org/10.1016/j.jconrel.2013.11.018
   PubMed Web of Science ®Google Scholar
• Wang H, Xu C, Kong X, Li X, Wang Y, Ding X, Yang Q. Trail resistance induces epithelial-mesenchymal transition and enhances invasiveness by suppressing PTEN via miR-221 in breast cancer. PloS one 2014; 9:e99067; PMID:24905916; http://dx.doi.org/10.1371/journal.pone.0099067
   PubMedGoogle Scholar
• Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012; 36:237-48; PMID:22459198; http://dx.doi.org/10.1016/j.canep.2012.02.007
   PubMed Web of Science ®Google Scholar
• Qu C, Zhang W, Zheng G, Zhang Z, Yin J, He Z. Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Mol Cell Biochem 2014; 386:63-71; PMID:24096736; http://dx.doi.org/10.1007/s11010-013-1845-x
   PubMed Web of Science ®Google Scholar
• Li S, Xie Y, Zhang W, Gao J, Wang M, Zheng G, Yin X, Xia H, Tao X. Interferon alpha-inducible protein 27 promotes epithelial-mesenchymal transition and induces ovarian tumorigenicity and stemness. J Surg Res 2015; 193:255-64; PMID:25103640; http://dx.doi.org/10.1016/j.jss.2014.06.055
   PubMed Web of Science ®Google Scholar
• Wang F, Dai W, Wang Y, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Li J, Zheng Y, et al. The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma. PloS one 2014; 9:e97414; PMID:24816638; http://dx.doi.org/10.1371/journal.pone.0097414
   PubMed Web of Science ®Google Scholar
• Li L, Han R, Xiao H, Lin C, Wang Y, Liu H, Li K, Chen H,Sun F, Yang Z, et al. Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clin Cancer Res 2014; 20:2714-26; PMID:24644001; http://dx.doi.org/10.1158/1078-0432.CCR-13-2613
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang X, Li J, Sun B, Qian H, Yin Z. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells. J Cancer Res Clin Oncol 2015; 141:189-201; PMID:24965746; http://dx.doi.org/10.1007/s00432-014-1752-x
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Song Y, Fu Z, Yu W. miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Mol Cancer 2014; 13:193; PMID:25128483; http://dx.doi.org/10.1186/1476-4598-13-193
   PubMed Web of Science ®Google Scholar
• Murray S, Briasoulis E, Linardou H, Bafaloukos D, Papadimitriou C. Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat Rev 2012; 38:890-903; PMID:22465195; http://dx.doi.org/10.1016/j.ctrv.2012.02.011
   PubMed Web of Science ®Google Scholar
• Chen SY, Hu SS, Dong Q, Cai JX, Zhang WP, Sun JY, Wang TT, Xie J, He HR, Xing JF, et al. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo. Asian Pac J Cancer Prev 2013; 14:6135-40; PMID:24289639; http://dx.doi.org/10.7314/APJCP.2013.14.10.6135
   PubMed Web of Science ®Google Scholar
• Chen S, Dong Q, Hu S, Cai J, Zhang W, Sun J, Wang T,Xie J, He H, Xing J, et al. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells. Mol Biosyst 2014; 10:294-303; PMID:24292090; http://dx.doi.org/10.1039/C3MB70428A
   PubMed Web of Science ®Google Scholar
• Cai J, Chen S, Zhang W, Hu S, Lu J, Xing J, Dong Y. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2. Phytomedicine 2014; 21:984-91; PMID:24680370; http://dx.doi.org/10.1016/j.phymed.2014.02.012
   PubMed Web of Science ®Google Scholar
• Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, et al. The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2012; 48:827-36; PMID:21745735; http://dx.doi.org/10.1016/j.ejca.2011.06.030
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhang R, Zhang L, Sun Y, Yao W, Zhao A, Li J, Yuan Y. Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer. Cancer Sci 2013; 104:423-30; PMID:23331552; http://dx.doi.org/10.1111/cas.12107
   PubMed Web of Science ®Google Scholar
• Li YJ, Duan CL, Liu JX. Salvianolic acid A promotes the acceleration of neovascularization in the ischemic rat myocardium and the functions of endothelial progenitor cells. J Ethnopharmacol 2014; 151:218-27; PMID:24189032; http://dx.doi.org/10.1016/j.jep.2013.10.019
   PubMed Web of Science ®Google Scholar
• Cai J, Chen S, Zhang W, Zheng X, Hu S, Pang C, Lu J, Xing J, Dong Y. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway. Phytomedicine 2014; 21:1725-32; PMID:25442283; http://dx.doi.org/10.1016/j.phymed.2014.08.007
   PubMed Web of Science ®Google Scholar
• Sun L, Zhao R, Zhang L, Zhang T, Xin W, Lan X, Huang C, Du G. Salvianolic acid A inhibits PDGF-BB induced vascular smooth muscle cell migration and proliferation while does not constrain endothelial cell proliferation and nitric oxide biosynthesis. Molecules 2012; 17:3333-47; PMID:22418933; http://dx.doi.org/10.3390/molecules17033333
   PubMed Web of Science ®Google Scholar
• Huanna T, Tao Z, Xiangfei W, Longfei A, Yuanyuan X, Jianhua W, Cuifang Z, Manjing J, Wenjing C, Shaochuan Q, et al. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7. Mol Carcinog 2014; PMID:24962947; http://dx.doi.org/10.1002/mc.22186
   PubMedGoogle Scholar
• Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q,Liu B, Yan M. CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway. PloS one 2014; 9:e112908; PMID:25398131; http://dx.doi.org/10.1371/journal.pone.0112908
   PubMed Web of Science ®Google Scholar
• Jiang L, He D, Yang D, Chen Z, Pan Q, Mao A, Cai Y, Li X, Xing H, Shi M, et al. MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway. FEBS Lett 2014; 588:2009-15; PMID:24786471; http://dx.doi.org/10.1016/j.febslet.2014.04.024
   PubMed Web of Science ®Google Scholar
• Wu Q, Wang R, Yang Q, Hou X, Chen S, Hou Y, Chen C, Yang Y, Miele L, Sarkar FH, et al. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway. Oncotarget 2013; 4:1999-2009; PMID:24158561
   PubMed Web of Science ®Google Scholar
• Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 2007; 31:277-83; PMID:17611683
   PubMed Web of Science ®Google Scholar
• Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen L, Zhu YH, Li J, Li Y, Ma S, et al. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3beta/Snail signaling. Hepatology 2014; 59:531-43; PMID:23929794; http://dx.doi.org/10.1002/hep.26677
   PubMed Web of Science ®Google Scholar
• Prinjha RK, Shapland CE, Hsuan JJ, Totty NF, Mason IJ, Lawson D. Cloning and sequencing of cDNAs encoding the actin cross-linking protein transgelin defines a new family of actin-associated proteins. Cell Motil Cytoskeleton 1994; 28:243-55; PMID:7954852; http://dx.doi.org/10.1002/cm.970280307
   PubMed Web of Science ®Google Scholar
• Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011; 104:808-18; PMID:21304530; http://dx.doi.org/10.1038/bjc.2011.23
   PubMed Web of Science ®Google Scholar
• Kim TR, Cho EW, Paik SG, Kim IG. Hypoxia-induced SM22alpha in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy. FEBS letters 2012; 586:303-9; PMID:22245152; http://dx.doi.org/10.1016/j.febslet.2011.12.036
   PubMed Web of Science ®Google Scholar
• Rho JH, Roehrl MH, Wang JY. Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res 2009; 8:5610-8; PMID:19848416; http://dx.doi.org/10.1021/pr900705r
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ye Y, Shen D, Jiang K, Zhang H, Sun W, Zhang J, Xu F, Cui Z, Wang S. Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci 2010; 101:523-9; PMID:19930159; http://dx.doi.org/10.1111/j.1349-7006.2009.01424.x
   PubMed Web of Science ®Google Scholar
• Wang X, Wang C, Zhang L, Li Y, Wang S, Wang J, Yuan C, Niu J, Wang C, Lu G. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells. Anti-Cancer Drugs 2015; 26:210-23; PMID:25419632; http://dx.doi.org/10.1097/CAD.0000000000000184
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu J, Li D, Chen J, Shen X, Xu F, Teng F,Deng Y, Ma H, Zhang L, et al. Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice. Phytomedicine 2014; 21:1137-45; PMID:24916705; http://dx.doi.org/10.1016/j.phymed.2014.05.003
   PubMed Web of Science ®Google Scholar
• Jiang B, Li D, Deng Y, Teng F, Chen J, Xue S, Kong X, Luo C, Shen X, Jiang H, et al. Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats. PLoS One 2013; 8:e59621; PMID:23533637; http://dx.doi.org/10.1371/journal.pone.0059621
   PubMedGoogle Scholar
• Yang LL, Li DY, Zhang YB, Zhu MY, Chen D, Xu TD. Salvianolic acid A inhibits angiotensin II-induced proliferation of human umbilical vein endothelial cells by attenuating the production of ROS. Acta Pharmacol Sin 2012; 33:41-8; PMID:22101169; http://dx.doi.org/10.1038/aps.2011.133
   PubMed Web of Science ®Google Scholar
• Chen S, Cai J, Zhang W, Zheng X, Hu S, Lu J, Xing J, Dong Y. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol 2014; 45:448-58; PMID:24736981; http://dx.doi.org/10.3892/ijo.2014.2389
   PubMed Web of Science ®Google Scholar